Patel Dhavalkumar Dhirajlal's Form 4 filing
Sana Biotechnology, Inc. (SANA) · filed Aug 27, 2026
- Accession no.
- 0002115339-26-000004
- Filed
- Aug 27, 2026, 4:21 PM ET
- Trade date
- Aug 26-27, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Patel Dhavalkumar DhirajlalCIK 0002115339 | Officer (EVP, Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Common Stock | MOption exerciseAcquired | +125,000 | $0.00 | $0 | 224,510 | Direct | |
| Aug 27, 2026 | Common Stock | FTax withholdingDisposed | −41,158 | $4.11 | −$169,159.38 | 183,352 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Common Stock | MOption exerciseDisposed | −125,000 | $0.00 | $0 | 250,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.